Search results
Results from the WOW.Com Content Network
The Doha Declaration on the TRIPS Agreement and Public Health was adopted by the WTO Ministerial Conference of 2001 in Doha on November 14, 2001. It reaffirmed flexibility of TRIPS (trade-related aspects of intellectual property rights) member states in circumventing patent rights for better access to essential medicines.
In 2001, developing countries, concerned that developed countries were insisting on an overly narrow reading of TRIPS, initiated a round of talks that resulted in the Doha Declaration. The Doha declaration is a WTO statement that clarifies the scope of TRIPS, stating for example that TRIPS can and should be interpreted in light of the goal "to ...
In addition. the Doha agenda included the topic of industrial tariffs, topics of interest to developing countries, changes to WTO rules, and other provisions. The second declaration dealt with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and allowed governments to be flexible with TRIPS to deal with health ...
The Doha Declaration responds to concerns of developing countries that patent protection rules and other IPRs were hindering access to affordable medicines for populations in those countries. [19] The Doha Declaration emphasizes the flexibility of the TRIPS Agreement and highlights the right of respective government to interpret the TRIPS ...
The Doha Declaration Adopted by the WTO Ministerial Conference of 2001 ; reaffirms flexibility of TRIPS member states in circumventing intellectual property rights for better access to essential medicines .
Doha conference can refer to several meetings held in Doha, Qatar: The WTO Ministerial Conference of 2001. leading to the Doha Development Round; and the Doha Declaration on the TRIPS Agreement and Public Health; 2008 follow-up conference to the Monterrey Consensus; Doha Agreement (2008) between rival Lebanese factions; Hamas–Fatah Doha ...
(Doha Declaration ¶ 5) Expressing the key concern of the Doha Declaration, paragraph 6 accepted the difficulties faced by countries with insufficient pharmaceutical manufacturing capabilities in “making effective use of compulsory licensing under the TRIPS Agreement,” and it instructed the Council for TRIPS to develop an “expeditious ...
Download QR code; Print/export Download as PDF; Printable version; In other projects Wikimedia Commons; ... Doha Declaration on the TRIPS agreement and public health; H.